EXAMINE THIS REPORT ON HEMGENIX

Quantity of eligible sufferers: CDEC talked about the uncertainty in the quantity of clients with reasonably significant to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some sufferers who're categorized as getting mild or average sickness could possibly have a crit